Chief Innovation Officer
Katie serves as Halloran’s Chief Development Officer and leads our consulting business and practices. Katie and her team focus on the development of assets, products, and portfolios and in optimizing life science organizations to improve performance through people, process, data, and technology. Katie often functions as an on-demand Head of Development, Head of Strategy, or Chief Operating Officer and advises on corporate strategic planning, directs clinical development portfolios, and provides recommendations to ease the challenges of drug development. As a member of the Executive Team, Katie focuses on designing the vision to fuel Halloran’s future growth and building the consulting team to deliver it. Katie is a Prosci certified Change Management Professional.
Prior to joining Halloran, Katie held a series of progressive positions with Biogen across several functions and roles, including Program and Alliance Management, Medical Research, Organizational Effectiveness, Clinical Development, and Clinical Operations. Before joining Biogen, Katie was a Clinical Research Coordinator at Massachusetts General Hospital.